RLI Corp. (NYSE: RLI) — A Best-in-Class Underwriter De-Rated to Its Cheapest Book in a Decade, as Earnings Crest and Insiders Buy

Independent fundamental equity research. As-of date: June 21, 2026.

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information only — not investment advice. It is the single place in this article a position and a directional valuation zone are taken; the analysis that follows carries no recommendation and no price target.

Verdict: HOLD / accumulate-on-weakness. Not a short. Medium conviction. RLI is the highest-quality specialty underwriter in the US P&C market — 30 consecutive years of underwriting profit, a fresh AM Best A++ rating, ~21% operating ROE, an ownership culture wired into compensation, and 50 straight years of dividend increases. The market has spent eighteen months taking it from ~4.6x book (Nov-2024) down to ~2.6x book (~$53) — the cheapest price-to-book in a decade and a ~39% drawdown in a 0.26-beta stock. That de-rate is not a fundamental break; it is the property-catastrophe pricing cycle visibly rolling over (E&S property rates −16% to −19% in Q1-26) on top of a benign-cat year that flattered 2025 earnings. So the tension is real: you are being offered a genuinely great business at a genuinely better-than-usual price, but on earnings that are near a cyclical peak. The tell that tips me to “accumulate-on-weakness” rather than a flat “avoid” is the first cluster of open-market insider buying in five years — CEO, COO, the independent Chairman, and a director all bought between ~$50 and ~$53 in May–June 2026. When the people who run a 30-year underwriting machine buy their own stock for the first time in half a decade, at a decade-cheap multiple, I pay attention.

Framing: out-of-favor quality / low-volatility, with a mild contrarian tilt — not momentum (relative strength is deeply negative, rs-from-peak −39%), and not a falling knife (an orderly, low-beta grind on a softening cat cycle, with the franchise fully intact). My directional zone: I’d accumulate in the ~$45–52 area (~2.2–2.5x book), where the dividend-plus-special yield approaches ~5% and you’re paying a discount to RLI’s own decade of book multiples for a business that compounds book value at mid-teens-plus through the cycle. Fair value ~$58–72 (~2.8–3.5x book) on a normalized high-teens-to-low-20s ROE. I would not chase it back toward $70+ (where it sat a year ago) and I would not short it — the quality and the A++ balance sheet make it a poor short regardless of cycle. Conviction: medium. The single fact that would flip me bullish: stabilization of property/E&S pricing (or a market-turning cat event) with the combined ratio holding in the mid-80s — i.e., evidence the ROE is structurally high, not cyclically high. The single fact that would flip me bearish: combined ratio drifting toward the low-90s as reserve releases fade and property pricing keeps falling, confirming the 2025 ROE was a peak the multiple should keep de-rating against. Tag: “The Dividend King the market marked down as the property tide went out.”

📈 Stock Price Action — Five-Year Event Map

RLI has round-tripped a full cycle: from a ~$44 low in early 2022 it roughly doubled to an all-time high of ~$87 in November 2024, then gave back ~39% to ~$53 today — a slow, persistent de-rating rather than a crash. The stock trades ~39% below its 5-year high, near the bottom of its 52-week range ($47.60–$72.87), and below its 200-day average. Beta is just 0.26; this is a low-volatility quality name that has been quietly re-rated down, not a high-beta blow-up. (Source: AZI 5-year split-adjusted price CSV; FactorsToday stock-info. All prices split-adjusted for the 2:1 split effective Jan 15, 2025.)

Cycle narrative. (1–2) RLI bottomed near $44 in the early-2022 rate shock, then the 2022 hard market plus the one-time Maui Jim windfall (a 40% equity stake sold to Kering Eyewear for $686.6M, a $571M pretax gain) drove record earnings and a +42% rebound. (3) 2023 was a digestion year — book value kept compounding but the stock idled near $63. (4) Through 2024 the stock rode peak property-catastrophe pricing and a building net-investment-income tailwind to an all-time high of ~$87 (~4.6–4.9x book) in November. (5) 2025 was the turn: as property/E&S rates began falling and the market recognized that a benign cat year and large reserve releases had flattered the ~22% ROE, the multiple de-rated and the stock fell ~21%; January’s LA wildfires added cat-headline noise (RLI’s actual loss was a modest $12M). (6) The grind continued into 2026 as E&S property rates fell another 16–19% — until a cluster of open-market insider purchases in May–June 2026 (CEO, COO, Chairman, a director, all at ~$50–53) put a marker under the stock. The price moves are facts; the attributed drivers are interpretation.

1. Executive Summary

RLI Corp. is a Peoria, Illinois specialty property-and-casualty insurer (founded 1965, public since 1980) that underwrites niche commercial and personal risks through three segments — Casualty (E&S casualty, commercial transportation, personal umbrella, professional/management liability), Property (E&S property, marine, Hawaii homeowners), and Surety (contract and commercial bonds). It is, by the numbers, the best underwriter in its peer group: FY2025 combined ratio of 83.6, a 30th consecutive year of underwriting profit (30-year average combined ratio ~88), ~21% operating ROE / ~22% GAAP ROE, and book-value-per-share growth (including dividends) of ~33% in 2025. In Q1-2026 AM Best upgraded the group to A++ (Superior) — a tier occupied by very few P&C carriers.

The investment question is not business quality — that is settled and exceptional. It is price against the cycle. Over eighteen months the stock has de-rated from ~4.6x book to ~2.6x book (~$53), the cheapest price-to-book multiple in a decade and a ~39% fall from its November-2024 high. The de-rate has a real cause: the property-catastrophe pricing cycle is softening hard (E&S property renewal rates fell 16–19% in Q1-26), and 2025’s headline ROE was flattered by an unusually benign catastrophe year (property combined ratio 57.2) and by reserve releases that contributed ~37% of underwriting income — a figure that has been declining for four years. Strip those and RLI’s normalized ROE is high-teens, not 22%.

Set against that: the franchise is intact and arguably strengthening (A++ rating, +12–15% net investment income as the bond book rolls into ~4.8% new-money yields, a hardening casualty/transportation cycle offsetting soft property), the balance sheet is fortress-grade, capital allocation is genuinely return-on-capital-driven, and — decisively — insiders bought the stock on the open market in May–June 2026 for the first time in five years. On its own decade of valuation history RLI is cheap; cross-sectionally against its ~21% ROE it is fair-to-attractive (it trades far below E&S pure-play Kinsale’s ~5.3x book, but Kinsale earns a 34% ROE and grows ~33%; RLI sits correctly above the standard-commercial cluster at ~1.3–1.8x book). The embedded-expectations read: at ~2.6x book the market is pricing RLI’s ROE to mean-revert toward the mid-teens and the multiple to stay compressed — a reasonable base case, but one the insider cluster and NII tailwind argue may be too pessimistic. No recommendation or price target appears below; the body analyzes embedded expectations and scenarios only.

2. Business Overview

RLI Corp. is a holding company whose insurance subsidiaries — RLI Insurance Company, Mt. Hawley Insurance Company (the excess-and-surplus-lines carrier), and Contractors Bonding and Insurance Company (surety) — underwrite specialty P&C coverages that standard-market carriers find too niche, too volatile, or too hard to price. The model is deliberately small and deep: ~1,147 employees, an underwriting-first culture, and a refusal to chase top-line growth when pricing is inadequate. RLI distributes through wholesale and retail brokers, independent and underwriting agents, branch offices, and carrier partners. (Source: FY2025 10-K; ROIC company profile.)

Three reportable segments (FY2025, gross premiums written / net premiums earned / combined ratio):

• Casualty — GPW ~$1,191M (+7%), NPE ~$954M, combined ratio 98.3. The largest and longest-tail segment. Lines include E&S general liability (heavily construction-tied), commercial transportation (trucking, public auto), personal umbrella (a large, growing book), professional liability (E&O), management liability (D&O, EPL, fiduciary), and package business for architects/engineers/contractors. Barely profitable on its own (98.3 CR) — this is where social-inflation severity bites, and where RLI’s underwriting discipline is most tested.
• Property — GPW ~$673M (−9%), NPE ~$512M, combined ratio 57.2. Short-tail and the FY2025 profit engine: E&S commercial property (cat-exposed), marine (a record ~$47M premium quarter in Q1-26), and Hawaii homeowners. The 57.2 combined ratio (vs 68.5 in 2024) reflects a benign cat year — cats added only ~5 points to the property loss ratio in 2025 vs ~19 points in 2024. This segment drove $219M of the $264M total underwriting income in 2025.
• Surety — GPW ~$163M (+1%), NPE ~$148M, combined ratio 80.3. Contract bonds for small-to-mid contractors, commercial surety for medium-to-large businesses, and transactional bonds. Capital-light, low loss ratio (7.2), sticky producer relationships — the analogue to Travelers’ “crown jewel” Bond & Specialty unit. Variable quarter-to-quarter around a small number of large losses.

How it makes money. Like all insurers, two engines: (1) underwriting profit — premiums earned minus losses and expenses, captured by the combined ratio (below 100 = profit); RLI’s ~84–88 through-cycle CR is elite. (2) net investment income — the “float” (policyholder reserves) invested in a $4.7B portfolio (76% investment-grade fixed income, 19% equities, ~4% cash; 4.8-year duration; 78% rated A or better). NII was $159.7M in 2025 (+12%) and is rising as bonds roll into higher yields. Revenue is overwhelmingly recurring (annual premium renewals); the business is not project-lumpy except within surety.

Verdict: A focused, high-return specialty underwriter with three complementary legs running on partially out-of-phase cycles (soft property, firm casualty, steady surety) — a genuinely diversified, recurring-revenue model, not a one-line bet.

3. Industry Dynamics

The US specialty/E&S P&C market is structurally attractive but cyclical, and RLI sits at the high-quality end of it. The excess-and-surplus segment — risks the admitted market won’t write at filed rates — has been a multi-year share-gainer: freedom of rate and form lets disciplined underwriters price hard-to-place risk and walk away when terms deteriorate. RLI’s Mt. Hawley is a long-tenured E&S franchise.

The defining feature of the 2025–2026 cycle is a sharp property-vs-casualty split — two capital cycles running out of phase, corroborated across the broader P&C cohort’s recent disclosures:

• Property is softening hard. After the highly profitable 2023–24 hard market, capital flooded in (the textbook Marathon capital-cycle top). Chubb’s management called large-account property rates “off 25%, heading to 30%” and “dumb”; Travelers/Marsh data showed US property −10%. RLI lived it directly: E&S property GPW −16% in Q1-26, with renewal rates down −19% (hurricane) and −16% (earthquake). Competition is intensifying from admitted-market programs and from broker-owned facilities and MGAs whose incentives, as RLI’s CEO pointedly noted, “are not always aligned with long-term underwriting profitability.”
• Casualty is firm but reserve-risky. Social inflation (rising jury verdicts, litigation funding, expanding liability) keeps long-tail casualty rates climbing — RLI’s commercial-transportation auto-liability rates rose +15% and personal-umbrella +16% in Q1-26 — but the same severity trend is why casualty reserves across the industry carry risk. Peers have taken sizeable reserve charges (Selective ~$311M in 2024 + ~$90M in 2025 on GL/commercial auto; Travelers asbestos top-ups). AM Best projects the industry combined ratio deteriorating ~1.9 points to ~96.9% in 2026 as earned-rate tailwinds plateau.
• NII is the cohort-wide reliable lever. Large IG portfolios rolling into ~5% new-money yields lift investment income for years with no underwriting risk — a tailwind that reverses only on sharp rate cuts.

Barriers to entry are moderate-to-high in the specialty niches RLI occupies: underwriting expertise, claims data, A++ balance-sheet strength (a real differentiator on long-tail and surety business), producer relationships, and regulatory/licensing scale. They are lower in commoditized cat property, which is precisely where the cycle is punishing everyone now. Switching costs are modest (insurance is re-bid annually) but real in surety (bonding relationships are sticky) and in expertise-led niches where RLI’s service and speed win renewals.

Verdict: A structurally good industry for a disciplined specialist, currently mid-cycle — soft and capital-flooded in property, firm but reserve-fraught in casualty. The cycle is the swing factor in RLI’s near-term earnings; its quality is what lets it shrink unprofitable lines and wait, as it is visibly doing.

4. Competitive Position

RLI’s moat is best described in Greenwald’s taxonomy as a cost/efficiency advantage rooted in underwriting selection and an ownership culture, reinforced by intangibles (A++ rating, niche expertise, producer trust) — and it shows up unmistakably in the financial outcome that a moat is supposed to produce. The proof is the combined ratio gap: RLI’s FY2025 combined ratio of 83.6 sits roughly 9 points below the ~92.6 P&C industry average, and its 30-year average (~88) means it has out-earned the industry’s underwriting result for three decades, not one lucky cycle. A company that can underwrite at a structural 8–10 point combined-ratio advantage for 30 years has a real, durable edge; the financial outcome (29–30 straight years of underwriting profit, 20%+ ROE) would deteriorate sharply without it. That is the test of a moat, and RLI passes it.

The mechanism. RLI is an underwriting company, not a premium-gathering one. Its compensation system pushes profit accountability down to the individual underwriter (an Underwriter Profit-Sharing Program), pays bonuses into a bonus bank with dollar-for-dollar clawback when business written later sours, and ties senior incentive comp to combined ratio, operating ROE, and returns above the cost of capital (MVP) rather than premium volume. Associates are owners (significant employee stock ownership). The cultural result is the observable behavior on display in Q1-26: RLI shrank property GPW 9–16% rather than match soft pricing, declined ~90% of transportation submissions, raised California personal-umbrella attachment points and cut commissions, and pulled back on excess commercial auto where severity is worst. Few public insurers willingly shrink a line to protect margin; RLI does it routinely.

Versus competitors. RLI’s natural comp set spans E&S/specialty peers. Kinsale (KNSL) is the closest pure-play E&S analogue and the quality benchmark — but it is a higher-growth, higher-ROE (34%) machine that earns its ~5.3x book multiple. W.R. Berkley (WRB) and Arch (ACGL) are larger, more diversified specialty writers. Cincinnati (CINF), Selective (SIGI), and Hartford (HIG) are closer on multiple but are broader standard-commercial carriers with lower, more volatile ROEs. RLI’s differentiation is consistency and quality of return rather than scale or growth: it does not have Kinsale’s growth runway, but it has a longer, smoother track record and now an A++ rating that even Kinsale lacks. Its weakness is the flip side — it is small (~$2B premium), producer- and geography-concentrated (49% of GPW through 10 producers; 56% of direct premium from FL/CA/TX/NY; ~⅓ tied to construction), and cat-exposed, so a single bad cat year or a construction recession hits harder than at a diversified giant.

Verdict: A durable, financially-proven competitive advantage — narrow in scope (specialty niches) but deep and well-defended by culture, rating, and discipline. This is a real moat, not a narrative one.

5. Growth History and Forward Opportunities

RLI is a compounder, not a grower — and management is explicit that it will sacrifice growth for underwriting profit. Net premiums earned grew from ~$988M (2020) to ~$1,614M (2025), a ~10% CAGR, but that masks a cyclical pattern: rapid growth into the 2021–2023 hard market, then deceleration as RLI pulls back from softening lines. FY2025 total GPW rose just +1% (Casualty +7%, Property −9%, Surety +1%), and Q1-2026 GPW +3% — modest by design.

The growth is overwhelmingly organic (RLI rarely acquires; it builds underwriting teams and niches). The composition in 2025–26 is informative: rate-and-mix-led, not exposure-led. Casualty premium +10% in Q1-26 was driven by personal umbrella (+23%, rate +16%) and commercial transportation (+27%, auto-liability rate +15%) — both hardening lines where RLI is leaning in with discipline. Property is shrinking on purpose. This is the right posture late in a property cycle, and it is the opposite of the MGAs chasing volume that management criticized.

Forward opportunities:

• Casualty/transportation hardening — “wheels-based” products are seeing rate acceleration and competitor pullback; RLI’s data/loss-control investments (telematics partnership with Netradyne; new-claim counts −14%) let it write growth at adequate rates while peers retreat.
• Net investment income — the most reliable forward lever: +12% in 2025, +15% in Q1-26, with new-money yields (~4.8%) ~50 bp above book yield. As the $4.7B portfolio rolls over, NII compounds with zero underwriting risk for several years.
• Surety expansion — local-contractor focus with new transactional-surety technology; a capital-light, high-return leg with room to grow off a small base.
• Property re-hardening optionality — when the property market turns (a major cat event, or capital exhaustion), RLI’s intact A++ capacity and patient posture let it re-enter aggressively. Management is explicitly “patient” and waiting for E&S property opportunities to “come back.”

Verdict: High-quality, low-quantity growth — disciplined, organic, rate-and-NII-driven. This is a mid-to-high-single-digit through-cycle premium grower that compounds book value at mid-teens-plus via underwriting profit + NII + reinvestment. Do not own RLI for top-line growth; own it for the durability and return on the growth it chooses to write.

6. Financial Quality

RLI’s economics are excellent and, with two clearly-labeled caveats, clean.

Returns. GAAP ROE has run 19.9% / 20.8% / 22.4% in 2023/24/25 (the 2022 figure of 43.6% is distorted — see below); operating ROE was 21.2% in 2025. ROIC is ~21%. These are top-of-cohort returns sustained over a decade, the financial signature of the moat described above. Margins: net profit margin ~21%; the combined ratio (the real margin metric) of 83.6 in 2025 is ~9 points better than industry.

Cash flow is high-quality. Operating cash flow was $560M (2024) and $614M (2025); OCF/net income has run ~1.5x consistently — operating earnings convert to more than 100% cash because float grows. Capex is trivial (~$5.5M). Free cash flow ~$609M in 2025. (The lone exception: 2022 OCF/NI of 0.43x, a pure artifact of the non-cash Maui Jim gain — see QoE.)

Balance sheet is fortress-grade. Equity $1.78B at YE2025; the investment portfolio ($4.7B) is 76% IG fixed income (78% rated A or better, 57% AA or better), 19% equities, ~4% cash, with a conservative 4.8-year duration. Debt was just $100M until March 2026, when RLI opportunistically issued $300M of 5.375% senior notes due 2036 and resized its revolver to $150M, returning leverage to its “historic average” — modest by any standard. The Q1-26 AM Best A++ upgrade is the third-party verdict on this balance sheet: top-tier financial strength, a genuine competitive asset on long-tail and surety business.

Quality-of-earnings flags (two, both labeled and manageable):

1. GAAP EPS includes unrealized equity-portfolio swings (post-2018 ASU). RLI’s $899M equity book marks to market through net income each quarter, adding volatility unrelated to underwriting (Q1-26 GAAP EPS $0.60 vs operating EPS $0.83 — the ~$39M unrealized equity loss is the gap; in 2025 unrealized/realized equity gains of ~$108M flattered GAAP earnings). The right lens for RLI is operating EPS and book value, not GAAP P/E. This is also why GAAP P/E (~12x) understates the multiple — operating earnings carry a low-to-mid-teens P/E.
2. Reserve releases are a real but declining contributor. FY2025 favorable prior-year development was ~$99M — about 37% of the $264M total underwriting income — and the trend is down (casualty PYD fell from $108.6M in 2021 to $32.8M in 2025). RLI has produced favorable development every year for at least five years (~$550M cumulative), which speaks to conservative reserving — but as the cushion thins and social inflation bites (commercial transportation and small-commercial lines showed adverse development within 2025 casualty, plus a $10M impairment on the Prime Holdings investee, from which RLI is exiting the quota-share treaty in 2026), the tailwind that has padded underwriting profit will fade. A normalized RLI — average cat year, smaller reserve releases — earns a high-teens ROE, not 22%. That is the crux of the valuation debate.

Verdict: Yes, the economics improve and persist with the franchise — high returns, clean cash conversion, fortress balance sheet. But 2025’s headline numbers sit near a cyclical peak (benign cats + still-large reserve releases), and the honest normalized return is high-teens. A high-quality earnings stream, correctly read through operating EPS and book value, with the cyclical caveat front-of-mind.

7. Capital Allocation

RLI’s capital allocation is disciplined and genuinely shareholder-aligned — among the strongest in the P&C group, and a clear positive in a sector where incentive misalignment is common.

Incentive structure (the foundation). Senior incentive compensation is tied to combined ratio, operating ROE (21.2% in 2025), Market Value Potential (after-tax returns above the cost of capital — $284M vs a $242M target in 2025), and a 5-year book-value-growth rank versus 13 peers (RLI ranked 2/13) — supported by a bonus-bank with dollar-for-dollar clawback and the underwriter profit-sharing program. This is return-on-capital, not premium-volume, alignment — the rare case where the proxy metrics would actually deter empire-building. Say-on-pay support exceeds 96%. Chair and CEO are split (independent Chairman David Duclos; CEO Craig Kliethermes the lone non-independent director) — a governance positive.

Distributions. RLI is a Dividend King: 50 consecutive years of regular-dividend increases, 198 consecutive quarters paid. Crucially, it has paid a special dividend every year since 2010 — $2.00/share specials in both Dec-2024 and Dec-2025 — its primary mechanism for returning excess capital without committing to a higher recurring payout. Total shareholder returns were ~$184M in 2025; ~$1.6B in dividends over a decade. The regular yield is modest (~1.2%) but the all-in yield including specials approaches ~5% at the current price.

What it does NOT do — and that’s deliberate. RLI ran no buyback in 2025 (treasury shares unchanged; share count even ticked up slightly on option exercises). This is intentional: RLI returns excess capital via special dividends rather than repurchases, preferring to keep capital deployable for hard-market opportunities and to avoid buying back stock at the ~4–5x book multiples it traded at in 2021–2024. (One can argue the de-rate to ~2.6x book in 2025–26 was a missed buyback window — a fair critique, though RLI’s framework favors specials and underwriting deployment over financial engineering.)

M&A. RLI almost never acquires; it builds. The most consequential capital event of the past five years was a divestiture — the 2022 sale of its 40% Maui Jim stake to Kering Eyewear for $686.6M (a $571M pretax gain), proceeds of which funded the large 2022 special dividend. It is also exiting the Prime Holdings quota-share reinsurance arrangement in 2026 after that investee deteriorated — pruning a non-core, underperforming relationship. Both are evidence of a management team that allocates by return, not by ambition.

Verdict: Management has allocated capital intelligently and with genuine alignment — disciplined underwriting deployment, return-on-capital incentives, fortress balance sheet, and a Dividend-King distribution record. The only nit is the absence of opportunistic buybacks into the 2025–26 de-rate. This is a clear thesis support, not a risk.

8. Changes and Headwinds — Last Two Years

• AM Best upgrade to A++ (Superior), Q1-2026. The most important recent development — top-tier financial strength, a tangible competitive asset (and notably one Kinsale does not hold). Strengthens the thesis. (8-K EX-99.1, Apr-2026.)
• Property-cat pricing roll-over (2025–26). The dominant headwind. E&S property GPW −9% to −16%, renewal rates −16% to −19%. RLI is responding correctly (shrinking, staying disciplined) but the segment that drove 83% of 2025 underwriting income is in a softening cycle. (Q1-26 transcript.)
• $300M senior-notes issuance, March 2026 (5.375%, due 2036) — opportunistic, returns leverage to historic norms; modest. (8-K, Mar-2026.)
• Insider buying cluster, May–June 2026 — the first open-market purchases in five years (CEO, COO, Chairman, director, ~$50–53). A meaningful change in insider posture and a conviction signal. (Form 4s.)
• LA wildfires, Q1-2025 — RLI’s net cat loss a modest $12M despite California being ~18% of direct premium; full-year 2025 cats ~$30M (a benign year overall). (FY2025 10-K; Q1-25 release.)
• Prime Holdings impairment / quota-share exit (2025–26) — $10M non-cash impairment on the 23% investee (commercial-auto deterioration); RLI exiting the reinsurance treaty in 2026. A small pruning, mildly negative on the affected casualty lines.
• Casualty social-inflation pressure — adverse development in commercial transportation and small-commercial within 2025; the sector-wide reserve risk is live for RLI too.
• 2:1 stock split, Jan-2025 — cosmetic; improves liquidity/retail access.

Verdict: A mix that modestly weakens the near-term earnings outlook (property soft, reserve releases fading, social inflation) while strengthening the long-term franchise (A++, NII tailwind, insider alignment). The thesis is intact; the cycle is the headwind.

9. Risk Analysis (Risk Matrix)

The asymmetry: RLI’s risks are overwhelmingly earnings-cyclical (combined ratio drifting up, ROE normalizing, multiple compressing), not existential. The A++ balance sheet, low leverage, and 30-year reserving record make a catastrophic permanent loss of capital genuinely remote — which is exactly why it is a poor short and a reasonable accumulate-on-weakness.

10. Valuation Discussion (Embedded Expectations)

For an insurer, price-to-book against ROE is the right lens; GAAP P/E is distorted here by mark-to-market equity swings. At ~$53 and a YE2025 GAAP book value of $20.49/share, RLI trades at ~2.6x book — versus its own decade range of 3.1x–4.9x (average ~3.7x). That is the cheapest price-to-book in a decade, corroborated by the AZI own-history composite valuation percentile (~24th) sitting in the cheap zone. (Note: the AZI raw P/B field reads 0.76x — a garbled book-value line; the correct figure from ROIC and the filings is ~2.6x. The own-history percentile direction is right; the absolute AZI P/B is wrong.)

The franchise multiple. Using P/B ≈ (ROE − g) / (COE − g): a sustained ~20–22% ROE with mid-single-digit growth and a ~9–10% cost of equity supports a multiple in the high-2x to low-3x book range. On that math, ~2.6x is fair-to-slightly-cheap for the trailing ROE — and clearly cheap if you believe the ROE is durable. The bear’s counter is that the durable ROE is high-teens, not 22% (benign cats + fading reserve releases flatter 2025), and a high-teens ROE supports ~2.2–2.6x — i.e., RLI is roughly fairly valued on normalized earnings, with downside to ~2x if the combined ratio drifts toward the low-90s.

Cross-sectional check. RLI’s ~2.6x book is rich against the standard-commercial cluster (CINF ~1.5x/15% ROE, SIGI ~1.35x/13%, HIG ~1.6x/16%, CB ~1.8x/16%, ACGL ~1.3x/17%) but cheap against the E&S quality benchmark Kinsale (~5.3x book / 34% ROE / ~33% growth). RLI belongs above the standard cluster (higher, cleaner, lower-vol ROE; A++; 30-year streak) and below Kinsale (lower growth) — which is exactly where ~2.6x places it. It is correctly slotted, not mispriced cross-sectionally; the opportunity is the own-history de-rate.

Scenario analysis (directional; not a target):

• Bear (~$42–48, ~2.0–2.3x book): property keeps softening, combined ratio drifts to low-90s, reserve releases shrink, ROE normalizes to mid-teens, multiple de-rates toward 2x. Total return modestly negative-to-flat; dividend cushions.
• Base (~$53–62, ~2.6–3.0x book): mixed cycle, combined ratio mid-80s-to-high-80s, ROE high-teens, NII compounds, multiple holds ~2.6–3.0x. Book value compounds ~mid-teens incl. dividends; total return mid-to-high single digits + special dividends.
• Bull (~$68–75, ~3.3–3.6x book): property cycle turns (cat event or capital exhaustion), RLI re-hardens its book, combined ratio stays mid-80s, ROE re-rated as structurally high (the A++/insider-buy thesis confirmed), multiple recovers toward its decade average ~3.7x.

Embedded expectations: at ~2.6x book the market is underwriting ROE mean-reversion to the mid-teens and a sustained multiple discount to RLI’s own history. Given the franchise quality, A++ upgrade, NII tailwind, and insider buying, that base case is defensible but arguably a touch too pessimistic — the source of the accumulate-on-weakness view in Claude’s Take. No price target; no recommendation.

11. Variant Perception

Consensus view: RLI is a wonderful business whose earnings are at a cyclical peak — benign cats, fat reserve releases, and a property hard market that is now over. The de-rate from ~4.6x to ~2.6x book is the market rationally re-pricing a normalizing ROE; the stock is “fairly valued on through-cycle earnings” and there is no near-term catalyst with property softening. Hold/avoid until the cycle turns.

Strongest bull case: This is a 30-year underwriting machine, freshly upgraded to A++, with a return-on-capital culture, that the market has handed you at its cheapest book multiple in a decade and a ~5% all-in dividend yield. The “peak earnings” fear over-weights property (now shrinking by design) and under-weights the offsetting hardening casualty/transportation cycle and the multi-year NII tailwind (+12–15%, compounding with zero underwriting risk). Normalized ROE is high-teens, not mid-teens, and high-teens on a quality compounder is worth more than 2.6x book. And the people who run the company just bought the stock on the open market for the first time in five years.

Strongest bear case: 2025’s 83.6 combined ratio and 22% ROE are a cyclical high you should not capitalize. Property — 83% of underwriting income — is in a steep, ongoing soft market with no bottom in sight. Reserve releases (37% of underwriting income) are fading and casualty is showing early adverse development as social inflation bites. Normalized ROE is mid-teens; at mid-teens, even ~2.6x book is no bargain, and the multiple can compress toward 2x (the standard-commercial cluster) — a 20–25% downside with no growth to bail you out. RLI is a great business at a fair price, and “fair” late in a cycle is a way to make nothing for two years.

The 3–5 assumptions that matter most:

1. Is the ~20–22% ROE durable (high-teens normalized) or cyclical (mid-teens)? — the entire valuation hinges here.
2. How much further does property/E&S pricing fall, and when does it bottom?
3. How fast do reserve releases fade, and does casualty social inflation produce adverse development?
4. Does the NII tailwind (+12–15%) persist long enough to offset underwriting margin compression?
5. Was the insider-buying cluster signal (valuation conviction) or noise?

Falsification: the bull breaks if the combined ratio drifts into the low-90s and reserve development turns adverse — proving the ROE was a peak. The bear breaks if the combined ratio holds in the mid-80s through the property soft market (NII + casualty + surety offsetting) — proving the ROE is structurally high and the de-rate overdone.

Factor-positioning read (FactorsToday): RLI loads positively on Low-Volatility, Value, and the Insurance industry factor (industry beta 0.88, market beta ~0.44), with deeply negative relative strength (rs-from-peak −39%, rs-12m −26%; m6/y1 Sharpe −1.4/−1.2). This is the empirical signature of an out-of-favor, low-volatility quality/value name being de-rated — not a crowded momentum trade (momentum loading is negative) and not a high-beta falling knife (beta 0.26; orderly grind). Factor-twins are CB, ACGL, HIG, and KNSL. For variant perception, the tape says consensus is offside bearish on a low-vol quality name — the conditions under which a contrarian/insider-aligned accumulation has historically paid, if the fundamental floor (mid-80s combined ratio) holds.

12. Fact vs. Interpretation Table

13. Open Questions

1. Where does the property/E&S soft market bottom, and how deep does the combined ratio damage go in 2026–27? Management is “patient” but won’t predict a turn.
2. How quickly do reserve releases normalize toward zero, and does casualty (transportation, GL) tip into net adverse development as social inflation compounds?
3. What is RLI’s true normalized through-cycle ROE — high-teens or mid-teens? The single most important unknown for valuation.
4. Will management deploy capital opportunistically (buyback) into the de-rate, or stick rigidly to specials-only? The 2025–26 window arguably warranted repurchases.
5. How large and lasting is the NII tailwind if the Fed cuts rates materially in 2026–27?
6. Is the insider-buying cluster a one-off valuation signal or the start of sustained accumulation? Watch subsequent Form 4s.
7. Does the construction-cycle exposure (~⅓ of business) become a headwind if the economy slows and project starts stall (already visible in Q1-26 E&S casualty)?

14. What Must Be True

Bull case — what must be true:

• RLI’s through-cycle ROE is structurally high-teens-plus, not mid-teens (the moat and culture persist).
• The combined ratio holds in the mid-80s through the property soft market, with hardening casualty/transportation + NII + surety offsetting soft property.
• Reserve development stays favorable (or only modestly fades) — no casualty social-inflation blowup.
• The multiple holds ~2.6–3.0x book or re-rates toward the decade average ~3.7x as the market re-recognizes the quality (aided by A++, insider buying).
• Falsification test: the bull case is wrong if the combined ratio drifts into the low-90s for two or more consecutive quarters and prior-year reserve development turns net adverse — proving 2025’s ROE was a peak the multiple should keep de-rating against.

Bear case — what must be true:

• 2025’s ~22% ROE was a cyclical peak; normalized ROE is mid-teens.
• Property pricing keeps falling with no near-term bottom; the segment that drove 83% of 2025 underwriting income compresses materially.
• Reserve releases fade toward zero and casualty develops adversely, pushing the combined ratio toward the low-90s.
• At a mid-teens ROE, ~2.6x book de-rates toward ~2x (the standard-commercial cluster), producing flat-to-negative total returns despite a healthy franchise.
• Falsification test: the bear case is wrong if RLI sustains a mid-80s combined ratio and ~20% operating ROE through a full year of soft property pricing — demonstrating the return is structural, not cyclical, and that ~2.6x book was too cheap.

The analysis above carries no buy/sell recommendation and no price target; valuation is discussed only as embedded expectations and scenarios. The single directional view in this article is the clearly-labeled opinion block at the top, which is the author’s own view and general information, not investment advice.

APPENDIX A — Standard Diligence Questionnaire

Supplemental to the research memo. Fact / Interpretation / Assumption labeled where it matters.

General

What thoughtful questions have other investors asked about this company? From the Q1-2026 call, sell-side focus is squarely on the cycle: (1) the competitive environment in general liability and how much of the construction-GL slowdown is timing vs. demand (Oppenheimer); (2) property pricing trajectory and whether it stabilizes in 2H-26 (Truist) — management: “not seeing signs of that yet”; (3) the durability of the transportation claim-count decline (real trend vs. reporting lag) — management: “cautiously, a real trend”; (4) the size/containment of the one large surety contract loss (KBW, Raymond James); (5) whether financial-lines (D&O/E&O) softening is hitting RLI — management: D&O “stabilizing,” flat rates “a win.” The throughline: is the underwriting margin defensible as the cycle softens? That is the right question, and the same one this memo centers on.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: near a high. FY2025’s 83.6 combined ratio and ~22% ROE were flattered by a benign catastrophe year (property CR 57.2; cats only ~5 pts vs ~19 in 2024) and by reserve releases (~37% of underwriting income, declining). Normalized ROE is high-teens.

Driven by the external environment or internal actions? Both. Internal: 30 years of underwriting discipline and culture (durable). External: the property hard market (2023–24, now reversing) and the higher-rate NII tailwind (still building). The cyclical swing is external; the through-cycle margin is internal.

How stable are revenues? Highly stable and recurring — annual premium renewals across three diversified segments. Top line is managed (RLI shrinks soft lines), so it decelerates by choice rather than collapsing.

Outlook for products/services; how big is the market — growing, shrinking, domestic or international? The US specialty/E&S market is a structural share-gainer (admitted business migrating to E&S). RLI is overwhelmingly domestic, small-and-deep. Casualty/transportation hardening (growing); property soft (shrinking by design); surety steady. Through-cycle mid-to-high-single-digit premium growth + NII compounding.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? More, currently — capital has flooded property (MGAs, broker facilities, alternative capital). Casualty is firm. RLI’s response is to shrink rather than match.

How profitable is the business (ROIC, ROE)? Elite: ROE ~20–22%, ROIC ~21%, combined ratio ~84–88 through cycle (~9 pts better than industry). 30 consecutive years of underwriting profit.

How profitable is the industry — competitors, barriers to entry? The broad P&C industry earns a ~92–97 combined ratio (modest underwriting margin; returns come largely from NII). RLI’s specialty niches are more profitable for disciplined specialists; barriers (expertise, A++ rating, data, producer trust, licensing) are moderate-to-high in niche lines, lower in commoditized cat property.

Can the business be easily understood? Yes, at a high level (underwrite niche risk profitably; invest the float conservatively), though loss-reserve adequacy and cat exposure require judgment.

Can it be undermined by foreign low-cost labor? No — domestic, expertise- and regulation-bound.

Do brands matter? Nature of competition? Switching costs? The “brand” is the A++ rating and underwriting reputation (matters for long-tail/surety capacity). Competition is on price, terms, and service. Switching costs are modest (annual re-bid) but real in surety (sticky bonding relationships) and expertise-led niches.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The franchise/underwriting culture (intangible) and conservative reserve cushion (favorable development every year). Minimal goodwill (~$46M).

Off-balance-sheet liabilities? Standard reinsurance recoverables and unearned-premium/loss reserves are on-balance-sheet; no unusual off-balance-sheet structures noted.

How conservative is the accounting? Conservative — consistent favorable reserve development (~$550M over 5 years), 4.8-yr conservative bond duration, high credit quality (78% A+). The one non-conservative GAAP feature is mandatory mark-to-market of the equity portfolio through net income (volatility, not aggressiveness) — RLI itself strips it out in operating EPS.

How CapEx-hungry? Not at all — capex ~$5.5M/yr (trivial). The capital intensity is regulatory (statutory surplus to support premium), not physical.

Capital Allocation & Management

How much FCF; how is it used; philosophy? FCF ~$609M (2025); OCF/NI ~1.5x. Used for: regular dividends (50-year King), annual special dividends (the primary excess-capital return, every year since 2010), statutory surplus to fund underwriting, and opportunistic debt management. Philosophy: return-on-capital discipline; deploy into underwriting when pricing is hard, return via specials when not.

Significant acquisitions recently? No. RLI builds rather than buys. The notable recent capital event was a divestiture — the 2022 Maui Jim stake sale ($686.6M, $571M pretax gain). Exiting the Prime Holdings quota-share treaty in 2026.

Buying back shares? No buyback in 2025 (share count flat-to-slightly-up on options). Deliberate — RLI favors specials over repurchases. Critique: arguably a missed opportunity to repurchase into the 2025–26 de-rate to ~2.6x book.

Issuing large amounts of stock to insiders? No — minimal SBC; share count essentially flat over five years. Insiders/directors own ~2.39%.

Compensation policy / motivations of management? A clear positive. Incentive comp tied to combined ratio, operating ROE (21.2%), Market Value Potential (returns above cost of capital), and 5-year book-value-growth rank vs. 13 peers (2/13) — plus a bonus bank with dollar-for-dollar clawback and an underwriter profit-sharing program. Chair/CEO split (independent Chairman). CEO total comp $7.7M (54:1 ratio). Genuinely shareholder-aligned, return-driven culture.

Valuation & Market Data

ADR, MLP, or K-1 issuer? None — ordinary US common stock, standard 1099 dividends. NYSE-listed.

Dividend policy? Regular quarterly dividend ($0.16/qtr, raised annually — 50 straight years) plus an annual special dividend ($2.00/sh in 2024 and 2025). All-in yield ~5% at the current price; regular yield ~1.2%.

How profitable is the business? Among the most profitable P&C underwriters (see ROE/combined ratio above).

Is net income diverging from cash from operations? OCF exceeds net income (~1.5x) — high-quality conversion. The lone divergence year (2022, OCF/NI 0.43x) was the non-cash Maui Jim gain.

Risks & Downside

What would cause the stock to decline? A major catastrophe year; combined ratio drifting toward the low-90s as property softens and reserve releases fade; casualty social-inflation adverse development; further multiple de-rating on perceived peak earnings; a sharp NII reversal on rate cuts.

Risk of catastrophic loss? Low. Cat exposure exists (FL/CA/TX, Hawaii) but is reinsured, modeled, and diversified; the A++ balance sheet and low leverage make a solvency event remote.

Chance of a total loss? Very low. A++ rated, conservatively reserved, low-leverage, 30-year profit record — permanent capital impairment is a remote tail.

Recent News & Events

Has the business environment changed recently? Yes — property-cat pricing rolling over (E&S rates −16/−19%), casualty/transportation hardening, and a soft (buyer’s) reinsurance market. AM Best upgraded RLI to A++ in Q1-2026.

Significant acquisitions? None. Exiting the Prime Holdings quota-share treaty (2026).

Change in accounting policies? From 2025, RLI excludes equity-in-earnings of unconsolidated investees from its operating-earnings definition (a presentation refinement, not a GAAP change).

Recent changes — new markets, facilities, management? 2:1 stock split (Jan-2025); $300M senior-notes issuance (Mar-2026); Netradyne telematics partnership in transportation (Nov-2025); first open-market insider buying in five years (May–June 2026). Stable senior leadership (CEO Kliethermes since 2022; CFO Diefenthaler; COO Klobnak).

APPENDIX B — Source Appendix

Primary sources prioritized.

Primary — SEC Filings (EDGAR, CIK 0000084246)

1. RLI Corp. Form 10-K, FY2025 — filed 2026-02-20. Segment results (Casualty/Property/Surety GPW, NPE, combined ratios), total combined ratio 83.6, net investment income $159.7M, investment portfolio composition (76% FI / 19% equity; 4.8-yr duration; 78% rated A or better), reserve-development table (Note 5), risk factors (Item 1A: catastrophe, reserve adequacy, reinsurance, competition/soft market, producer & geographic concentration). https://www.sec.gov/Archives/edgar/data/84246/000110465926018013/rli-20251231x10k.htm
2. RLI Corp. Form 10-K, FY2022 — filed 2023-02-24. Maui Jim, Inc. (40% equity interest) sale to Kering Eyewear (9/30/2022) for $686.6M cash, $571.0M pretax net realized gain (Note 13); Prime Holdings equity-method investee.
3. RLI Corp. Form 10-K, FY2023 and FY2024 — multi-year segment and reserve-development comparatives; combined-ratio streak.
4. RLI Corp. Form 8-K, March 3, 2026 — $300M 5.375% Senior Notes due 2036; revolver resized to $150M (PNC).
5. RLI Corp. Form 8-K (EX-99.1 press release), April 2026 — Q1-2026 results; AM Best upgrade of the RLI group to A++ (Superior), Long-Term ICR to “aa+”.
6. RLI Corp. Form 8-K (EX-99.1), Q1-2025 — LA wildfire net catastrophe loss ~$12M.
7. RLI Corp. DEF 14A (proxy), filed 2026-03-26 — executive compensation metrics (combined ratio, operating ROE 21.2%, Market Value Potential, 5-year book-value-growth rank vs. 13 peers, bonus bank with clawback, underwriter profit-sharing); CEO Kliethermes total comp $7,691,732 (54:1 ratio); independent Chairman (Duclos); insider ownership 2.39%; dividend record.
8. RLI Corp. Forms 3/4/5 (2021–2026 corpus, 260+ filings) — insider-transaction history: no open-market purchases for five years until the May–June 2026 cluster (CEO Kliethermes, COO Klobnak, Chairman Duclos, director Kellogg; ~16,500 shares at ~$50–53).

Primary — Earnings Call

9. RLI Corp. Q1-2026 earnings call transcript — April 23, 2026 (via ROIC.ai). Operating EPS $0.83 (GAAP $0.60), combined ratio 86%, GPW +3%, NII +15%; segment detail (Casualty +10%/97 CR, personal umbrella +23%, transportation +27%; Property −9%/62 CR, E&S property −16%/rates −19% hurricane/−16% EQ; Surety −1%/94 CR); $300M notes issuance; AM Best A++ upgrade; reinvestment yield 4.8% vs ~4.3% book yield; management cycle commentary (property softening, casualty hardening, MGA/broker-facility competition).

Quantitative Data Sources

10. ROIC.ai MCP — income statement, balance sheet, cash flow, per-share data, profitability ratios (ROE 22.4% FY25, ROIC ~21%), enterprise value, and valuation-multiple history (P/B 3.1–4.9x over the decade; FY25 P/B 3.12x at year-end close, ~2.6x at current price). Third-party aggregated; reconciled to filings. Company profile (CEO, employees, segment description).
11. AZI / azitrading.com — 5-year split-adjusted price CSV (price action, 5yr low $43.93 / high $87.12 / current $53.09; beta 0.26); own-history valuation percentiles (composite ~24th, P/E ~26th, P/S ~44th; P/B field garbled — disregarded); news feed (insider Form-4 headlines, Q1-results benchmarking).
12. FactorsToday (factorstoday.com/api) — factor loadings (Insurance-industry beta 0.88, market beta ~0.44, Low-Volatility and Value positive, Momentum negative; R² 0.53), leaderboard (rs-from-peak −39%, rs-12m −26%, m6/y1 Sharpe −1.4/−1.2), related/factor-twin stocks (CB, ACGL, HIG, KNSL).

Peer / Industry Context (cross-read prior work and comps)

13. Peer valuation comps (ROIC.ai, FY2025) — KNSL (P/B ~5.3x / ROE 34%), WRB (~2.1x / ~19–20% reported), CB (~1.8x / 16%), ACGL (~1.3x / 17%), CINF (~1.5x / 15%), SIGI (~1.35x / 13%), HIG (~1.6x / 16%), AFG (~3.3x / 25%, flattered by goodwill), MKL (~1.4x / 12%).
14. Industry cycle framing — corroborated against prior P&C research on Chubb, Travelers, Progressive, and Allstate (property soft market −10% to −30%; casualty firm +9–18%; social-inflation reserve risk; NII tailwind; AM Best 2026 industry combined-ratio outlook ~96.9%). Underlying public sources: company Q1-2026 disclosures, Marsh/AM Best commentary as cited therein.

Frameworks Applied

15. Competition Demystified (Greenwald & Kahn) — moat-type taxonomy (RLI = cost/efficiency + intangibles), share-stability and ROIC tests.
16. Capital Returns (Marathon Asset Management) — capital-cycle lens on the property soft market (capital flooding a previously profitable segment → mean-reverting returns).

Access date for all online sources: June 21, 2026.